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During mitosis of human cells, the kinase Bub1
orchestrates chromosome segregation through
phosphorylating histone H2A and the anaphase-pro-
moting complex/cyclosome activator Cdc20. Bub1-
mediated H2A-T120 phosphorylation (H2A-pT120)
at kinetochores promotes centromeric sister-chro-
matid cohesion, whereas Cdc20 phosphorylation
by Bub1 contributes to spindle checkpoint signaling.
Here, we show that phosphorylation at the P+1 sub-
strate-binding loop of human Bub1 enhances its ac-
tivity toward H2A but has no effect on its activity
toward Cdc20. We determine the crystal structure
of phosphorylated Bub1. A comparison between
structures of phosphorylated and unphosphorylated
Bub1 reveals phosphorylation-triggered reorganiza-
tion of the P+1 loop. This activating phosphorylation
of Bub1 is constitutive during the cell cycle. Enrich-
ment of H2A-pT120 at mitotic kinetochores requires
kinetochore targeting of Bub1. The P+1 loop phos-
phorylation of Bub1 appears to occur through intra-
molecular autophosphorylation. Our study provides
structural and functional insights into substrate-spe-
cific regulation of a key mitotic kinase and expands
the repertoire of kinase activation mechanisms.
INTRODUCTION
The mitotic serine/threonine kinase Bub1 has multiple functions
in chromosome segregation. Mice harboring a catalytically inac-
tive Bub1mutant exhibit increased chromosome segregation er-
rors andaneuploidy (Rickeet al., 2012). Bub1has twoknownsub-
strates in human cells, Cdc20andhistoneH2A (Kawashimaet al.,
2010; Tang et al., 2004a). Cdc20 is an activator of the anaphase-
promoting complex or cyclosome (APC/C), a ubiquitin ligase
essential for anaphase onset (Yu, 2007). In response to kineto-
chores not properly attached to spindlemicrotubules, the spindle
checkpoint inhibits APC/CCdc20 to delay anaphase onset (Foley
and Kapoor, 2013; Jia et al., 2013; Lara-Gonzalez et al., 2012).1616 Structure 22, 1616–1627, November 4, 2014 ª2014 Elsevier LtdPhosphorylation of the N-terminal region of Cdc20 by Bub1 con-
tributes to checkpoint-dependent inhibition of APC/CCdc20 (Tang
et al., 2004a). Bub1 also phosphorylates histoneH2Aat threonine
120 (H2A-T120) (Kawashima et al., 2010). H2A-pT120 is enriched
at mitotic kinetochores (Liu et al., 2013a) and creates a docking
site for thecomplexof shugoshin (Sgo1) andproteinphosphatase
2A (PP2A) (Kawashima et al., 2010; Kitajima et al., 2005, 2006;
Riedel et al., 2006; Tanget al., 2004b, 2006),whichbinds andpro-
tects cohesin at centromeres until the metaphase-anaphase
transition (Liu et al., 2013b). Thus, the kinase activity of Bub1 is
critical for multiple steps of chromosome segregation.
Despite these critical functions, whether and how the kinase
activity of Bub1 is regulated during the cell cycle are poorly un-
derstood. We have previously determined the crystal structure
of the Bub1 kinase domain (Kang et al., 2008). Although much
of the activation segment of Bub1 in that structure has an
ordered conformation characteristic of active kinases, the P+1
substrate-binding loop partially blocks the active site and is
not optimal for substrate binding (Kang et al., 2008). The mech-
anism by which Bub1 reorganizes its P+1 loop for efficient sub-
strate phosphorylation is unknown.
Here we show that phosphorylation of S969 of the P+1 loop in
human Bub1 selectively enhances its activity toward H2A-T120
but does not affect its activity toward Cdc20. We determine the
crystal structure of the Bub1 kinase domain containing phos-
pho-S969, revealing a phosphorylation-induced conformational
change in the P+1 loop. Surprisingly, the Bub1-pS969 level is
not elevated during mitosis. The kinetochore enrichment of H2A-
pT120 inmitosis instead relies on themitosis-specific kinetochore
targeting of Bub1. Bub1-pS969 is mediated by intramolecular au-
tophosphorylation, which does not strictly require the catalytic
aspartate. Our study thus defines an unusual mode of autoactiva-
tion forBub1andprovidesamechanismbywhich theactivitiesofa
kinase toward different substrates can be differentially regulated.RESULTS
P+1 Loop Phosphorylation Stimulates the Kinase
Activity of Bub1 toward H2A
Bub1 consists of an N-terminal tetratricopeptide repeat (TPR)
domain, a central Cdc20-binding domain (CBD), and a C-termi-
nal serine/threonine kinase domain (Figure 1A). The CBDAll rights reserved
Figure 1. S969 Phosphorylation Is Required Specifically for the Activity of Bub1 toward H2A
(A) Schematic drawing of the domains and motifs of human Bub1. CBD, Cdc20-binding domain; GLEBS, Gle2-binding sequence; KEN, Lys-Glu-Asn box; TPR,
tetratricopeptide repeat.
(B) Sequence alignment of the activation segment of Bub1 proteins. Hs, Homo sapiens; Mm,Mus musculus; Sc, Saccharomyces cerevisiae; Xl, Xenopus laevis.
Identical residues are shaded yellow. S969 in human Bub1 and its corresponding residues are colored red.
(C)HeLacellswere transfectedwith the indicatedMyc-Bub1plasmidsandsynchronizedatG1/Swith thymidine (Thy), atmitosiswith nocodazole (Noc), or at earlyG1
with nocodazole-arrest release. The mitotic index of each sample was indicated at the bottom. Myc-Bub1 proteins were immunoprecipitated with the anti-Myc
antibody beads and subjected to kinase assayswithCdc20 or bulk histones as substrates. The kinase reactionmixtureswere blotted with the indicated antibodies.
(D) The H2A-pT120 and Cdc20-pS153 signals in (C) were quantified and normalized against the total H2A and Cdc20 levels, respectively.
(E) Recombinant purified WT or mutant Bub1740–1085 were assayed for their activities toward H2A and Cdc20. The reaction mixtures were blotted with the
indicated antibodies.
(F) HeLa cells were transfected with the indicated Myc-Bub1 vectors and treated with thymidine (Thy), Taxol (Tax), or Taxol followed by MG132 (MG) and the
Aurora kinase inhibitor ZM447439 (ZM). Myc-Bub1 proteins were immunoprecipitated from cell lysates, either untreated or treated with l phosphatase (PPase),
and blotted with the indicated antibodies.
See also Figure S1.
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Structure
Crystal Structure of Activated Bub1contains a KEN box that interacts with the C-terminal WD40
repeat domain of Cdc20. Using mass spectrometry, we mapped
the phosphorylation sites of recombinant human Bub1 ex-
pressed in insect cells, which was active in phosphorylating
both Cdc20 and H2A. One of the phosphoresidues, S969, is
located in the P+1 loop and is conserved among vertebrate
Bub1 proteins (Figure 1B and Figure S1A available online). To
examine the effect of S969 phosphorylation, we mutated this
residue to alanine or aspartate. The neighboring residue T968
is also conserved in vertebrates. To avoid potential compensa-
tion for the loss of S969 phosphorylation through T968 phos-
phorylation, we also created the T968A mutant and the T968A/
S969A (AA) double mutant.
We then expressed Myc-Bub1 wild-type (WT) or mutants in
HeLa cells, arrested these cells in mitosis with nocodazole,
immunoprecipitated Myc-Bub1 proteins, and assayed their ac-
tivities in vitro toward histone H2A or Cdc20 using phospho-spe-
cific antibodies (Figures 1C and 1D). Two different kinase-dead
mutants, D917N and D946N, were used as negative controls.
The D917Nmutant has the catalytic aspartate mutated but is ex-
pected to retain ATP binding. The D946N mutation targets a key
Mg2+-coordinating residue and disrupts ATP binding. As ex-
pected, both mutants were inactive toward H2A or Cdc20.
Myc-Bub1 proteins isolated from G1 cells (thymidine-arrested
or nocodazole-arrest-release samples) or mitotic cells (nocoda-
zole-arrested samples) had similar activities toward both histone
H2A and Cdc20, suggesting that the kinase activity of Bub1
might not be regulated during the cell cycle.
S969A had much weaker activity toward H2A-T120, whereas
the activity of S969D was similar to that of WT. Consistent with
our previous study (Kang et al., 2008), S969A largely retained
its activity toward Cdc20 (Figures 1C and 1D). Similar results
were obtained with recombinant purified WT, S969A, and
S969D Bub1 kinase domain proteins (containing residues 740–
1085) (Figure 1E). These results suggest that S969 phosphoryla-
tion of Bub1 is required for its activity toward H2A but appears to
be dispensable for Cdc20 phosphorylation.
The T968A mutation greatly reduced the activity of Bub1 to-
ward H2A. As reported previously (Kang et al., 2008), Bub1
T968A had diminished activity toward an N-terminal fragment
of Cdc20. Interestingly, the T968A and AA mutants largely re-
tained their activities toward full-length Cdc20. Compared
with the N-terminal fragment of Cdc20, the full-length Cdc20
was a better substrate for Bub1 because it could be recruited
to Bub1 through a docking interaction between its C-terminal
WD40 domain and the CBD of Bub1 (Kang et al., 2008). To
clarify the role of T968 in H2A phosphorylation, we immunized
rabbits with a mixture of two phosphopeptides containing
either pT968 or pS969 and affinity purified the antibodies using
either peptide. The antibody mixture and the pS969 antibody
detected the recombinant Bub1 kinase domain protein from in-
sect cells (Figure 1E) and Myc-Bub1 from HeLa cells (Figure 1F),
but not the S969A mutant. The Myc-Bub1 signals were abol-
ished by phosphatase treatment (Figure 1F). The pT968 anti-
body detected no signals (data not shown). Moreover, Myc-
Bub1 T968A retained the pS969 signal (Figure 1F). Therefore,
Bub1 T968 is itself not phosphorylated and is not required for
S969 phosphorylation. T968 likely plays a structural role in
phosphorylating substrates and may directly participate in the1618 Structure 22, 1616–1627, November 4, 2014 ª2014 Elsevier Ltdrecognition of the H2A or Cdc20 peptides. The full-length
Cdc20 can interact with docking motifs on Bub1 that are
outside its kinase domain. This docking mechanism presum-
ably compensates for the weakened local interactions between
T968 and residues neighboring the Cdc20 phosphorylation site
in Bub1 T968A.
We were intrigued by two previous reports that implicated the
N-terminal TPR domain of Bub1 in regulating its kinase activity
(Krenn et al., 2012; Ricke et al., 2012), as this result suggested
the potential existence of long-range interactions between the
TPR and kinase domains. In contrast to these reports, however,
we found that the Bub1 mutant with its TPR deleted (DTPR)
expressed in human or insect cells was fully active in phosphor-
ylating Cdc20 and H2A (Figures 1C, 1D, S1B, and S1C). Consis-
tently, Bub1 DTPR had normal levels of S969 phosphorylation
(Figures 1F and S1C). Thus, the TPR domain of Bub1 is dispens-
able for its kinase activity.
Both previous studies relied on kinase assays with tagged
Bub1 proteins overexpressed in and immunoprecipitated from
mammalian cells. The effects of TPR deletion on the kinase ac-
tivities of immunoprecipitated Bub1 in these studies were likely
indirect andmight involve other Bub1-binding proteins. Because
we did not observe activity differences with Myc-Bub1 proteins
overexpressed in HeLa cells, the indirect effects of TPR might
be variable among cell lines or types or might be sensitive to
immunoprecipitation (IP) conditions.
Structure of the Bub1 Kinase Domain with
Phosphorylated S969
We had previously determined the structure of the extended ki-
nase domain of Bub1 (residues 724–1085), in which S969 was
not phosphorylated (Kang et al., 2008). Compared with
Bub1724–1085, a smaller Bub1 fragment (residues 740–1085)
was more efficient in undergoing autophosphorylation at S969
(Figure 2A). Bub1740–1085 was also more active in phosphory-
lating histone H2A. These results provide direct evidence that
phospho-Bub1 is more active than the unphosphorylated Bub1
toward H2A, although we cannot rule out the possibility that res-
idues 724–739 (missing in the phospho-Bub1 protein) might
have an autoinhibitory role in H2A phosphorylation. Importantly,
the phosphorylated and unphosphorylated Bub1 proteins can be
separated by cation exchange chromatography (Figure 2B), with
pS969 Bub1 eluting at lower salt. About 30%of Bub1740–1085 pu-
rified from insect cells was already phosphorylated at S969.
When the unphosphorylated and phosphorylated Bub1740–1085
were incubated with H2A in the kinase buffer for only 15 min,
we did not observe substantial differences in pS969 or pH2A
levels at the end of the reaction. Thus, the autophosphorylation
reaction likely proceeds with kinetics faster than those of the
H2A phosphorylation reaction.
We then incubated the unphosphorylated Bub1 fractions with
the kinase buffer containing cold ATP. Virtually all of the Bub1
protein was phosphorylated after this incubation, based on its
fractionation profile on the cation exchange column. The frac-
tions corresponding to phosphorylated Bub1 was collected
and subjected to crystallization. We obtained diffracting crystals
of phosphorylated Bub1 and determined its structure using mo-
lecular replacement with the structure of unphosphorylated
Bub1 (PDB ID 3E7E) as the search model (Figures 2C and 2D).All rights reserved
Figure 2. S969 Phosphorylation Induces
Localized Conformational Change of the
Bub1 P+1 Loop
(A) Recombinant purified Bub1724–1085 and
Bub1740–1085 proteins were assayed for their ac-
tivities toward H2A. The reaction mixtures were
blotted with anti-H2A and anti-H2A-pT120 anti-
bodies. The Bub1 proteins prior to the kinase
reactions were also blotted with anti-Bub1 and
anti-Bub1-pS969 antibodies.
(B) Resource S fractions of Bub1740–1085 were
blotted with the anti-Bub1-pS969 antibody or
stained with Coomassie (two top panels). The
same fractions were incubated with H2A and cold
ATP in the kinase buffer for 15 min. The reaction
mixtures were blotted with anti-Bub1-pS969 and
anti-H2A-pT120 antibodies (two bottom panels).
(C) Ribbon diagram of unphosphorylated Bub1,
with ADP and key residues shown as sticks. The
N-terminal extension is in gray. The activation
segment is colored blue. The P+1 loop is colored
purple. The rest of the protein is in light cyan. Mg2+
ions are shown as gray spheres. The N and C
termini are labeled. All structure figuresweremade
with Pymol (http://www.pymol.org).
(D) Ribbon diagram of phospho-S969 Bub1, with
ADP and key residues (including pS969) shown as
sticks. The N-terminal extension is in gray. The
activation segment is colored blue. The phos-
phorylated P+1 loop is colored green. The rest of
the protein is in cyan.
(E) Overlay of the active site of unphosphorylated
and phosphorylated Bub1. Color schedules are as
in (C) and (D).
(F) Electron density (plotted at 1s) of the phos-
phorylated P+1 loop.
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Crystal Structure of Activated Bub1During the refinement of the phosphorylated Bub1 structure,
we discovered that modeling of the bound nucleotide as ATP
with one Mg2+ ion coordinated to the a and b phosphates re-
sulted in severe distortions of the geometry and regions of large
positive and negative density for the atoms of the g phosphate.
Reducing the occupancy of the g phosphate atoms to less
than 1.0 and re-refinement, as had been done in the original
refinement for the unphosphorylated Bub1, did not eliminate
the geometry distortions and electron density. Inclusion of a fully
occupied ADP, with a second Mg2+ ion bound to three water
molecules (in place of the g phosphate of ATP that was originally
modeled), resolved all refinement issues. A re-examination of the
unphosphorylated Bub1 structure led us to conclude that this
structure also contains one fully occupied ADP and two bound
Mg2+ ions with tightly bound waters. Statistics for data collection
and structure refinement for both unphosphorylated and phos-
phorylated Bub1 are included in Table 1.
The structure of pS969-Bub1 is virtually identical to that of un-
phosphorylated Bub1, except the conformations of their P+1Structure 22, 1616–1627, November 4, 2014 ªloop (Figures 2C–2E). The electron den-
sity of the P+1 loop of phospho-Bub1 is
generally well defined, with pS969 being
clearly visible (Figure 2F). The P+1 loops
in both unphosphorylated and phosphor-
ylated Bub1 have B factors higher thanthose of the rest of the protein, indicative of partial disorder in
both cases. S969 phosphorylation substantially reorganized
the conformation of the P+1 loop. In the unphosphorylated state,
S969 points toward the active site. In the phosphorylated state, a
part of P+1 loop containing pS969 forms a 310 helix, with pS969
pointing away from the active site.
Despite repeated attempts, we could not determine the struc-
ture of phospho-Bub1 bound to H2A peptides. The underlying
reason for why pS969 enhances the Bub1 activity toward H2A
remains unclear. Because S969 phosphorylation has little effect
on Bub1-catalyzed Cdc20 phosphorylation, the conformation of
the phosphorylated P+1 loop of Bub1 may be specifically opti-
mized for H2A binding. For example, pS969 may make direct
contact with the H2A peptide (VLLPKKTESHKAK), which has
basic residues at 1 and 2 positions. In contrast, the Cdc20
S153 phosphorylation site (RLKVLYSQKATPG) has hydrophobic
residues at 1, 2, and 3 positions, providing a possible
reason for why Cdc20 phosphorylation is insensitive to Bub1
S969 phosphorylation. The two basic residues at 1/22014 Elsevier Ltd All rights reserved 1619
Table 1. Data Collection and Refinement Statistics of
Unphosphorylated and pS969 Bub1
Data Collection
Crystal unphosphorylated
Bub1
pS969 Bub1
Space group C2221 P21
Cell parameters
(a, b, c, b)
108.8 A˚, 147.6 A˚,
47.2 A˚
90.0 A˚, 47.2 A˚,
93.1 A˚, 107.4
Energy (eV) 12,679.4 12,664.5
Resolution range (A˚) 32.51–2.32
(2.36–2.32)a
36.89–2.20
(2.24–2.20)
Unique reflections 16,738 (862) 37,658 (1,707)
Multiplicity 5.4 (5.6) 3.7 (3.0)
Data completeness (%) 97.7 (100.0) 98.4 (88.9)
Rmerge (%)
b 3.7 (73.1) 11.4 (39.4)
I/s(I) 37.8 (2.1) 16.1 (2.4)
Wilson B value (A˚2) 30.4 32.3
Refinement Statistics
Crystal unphosphorylated
Bub1
pS969 Bub1
Resolution range (A˚) 32.51–2.32
(2.40–2.32)
36.89–2.20
(2.26–2.20)
No. of reflections
Rwork/Rfree
16,638/1,288
(1,626/151)
37,581/1,884
(2,430/130)
Data completeness (%) 97.1 (95.0) 98.1 (87.0)
Atoms (non-H protein/
ligands/waters)
2693/29/16 5,374/61/237
Rwork (%) 22.2 (32.3) 22.9 (26.4)
Rfree (%) 26.4 (37.6) 26.8 (32.5)
Rmsd bond length (A˚) 0.005 0.005
Rmsd bond angle () 0.822 0.747
Mean B value (A˚2)
(protein/ligands/
waters)
43.6/27.4/26.1 46.0/30.2/37.7
Ramachandran plot (%)
(favored/additional/
disallowed)c
96.3/3.7/0 95.8/4.2/0
Maximum likelihood
coordinate error
0.29 0.32
Missing residues A: 726–735, 807–815,
932–938, 1084–1085
A: 807–814, 932–938,
1084–1085;
B: 807–815, 932–936,
1082–1085
aData for the outermost shell are given in parentheses.
bRmerge = 100 ShSijIh, i— hIhij/ShSiIh, i, where the outer sum (h) is over the
unique reflections and the inner sum (i) is over the set of independent ob-
servations of each unique reflection.
cAs defined by the validation suite MolProbity (Chen et al., 2010).
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Crystal Structure of Activated Bub1positions in H2A may form favorable electrostatic interactions
with Bub1 pS969, whereas the hydrophobic residues of Cdc20
at the corresponding positions cannot. Another possible reason
for why Cdc20 phosphorylation does not require Bub1 S969
phosphorylation may be the existence of the distal docking
interaction between the WD40 domain of Cdc20 and the CBD
of Bub1.1620 Structure 22, 1616–1627, November 4, 2014 ª2014 Elsevier LtdStructural Basis of the Conformational Change
Triggered by S969 Phosphorylation
The catalytic loop and activation segment of Bub1 have several
unusual features (Figure S2). The N-terminal half of the activation
segment is ordered and has virtually identical conformations in
both the unphosphorylated and phosphorylated Bub1 (Figures
3A and 3B). The DLG motif (DFG in most other kinases) at the
start of the activation segment is critical for Mg2+ binding. A high-
ly conserved aspartate (D952) is engaged in electrostatic and
hydrogen bonding interactions with R840 and Y832 on the aC
helix. Several residues in the N-terminal portion of the activation
segment, including I951, M953, L955, F956, P957, T960, and
F962, develop extensive hydrophobic interactions with F736,
V738, P741, W742, L746, and L750 from the N-terminal exten-
sion, I914 from the catalytic loop, andW982 and Y984 N terminal
to the aF helix. Most of these interactions are retained in phos-
phorylated Bub1, except those involving F736 and V738. These
residues are deleted in this shorter Bub1 protein. A proline from
the cloning sites takes their place. Because the N-terminal
extension is critical for the kinase activity of Bub1, this important
difference might help to explain why Bub1740–1085 is more active
than Bub1724–1085.
In many kinases in which activation involves activation
segment phosphorylation, their catalytic loop contains a charac-
teristic HRD motif, in which the arginine forms favorable electro-
static interactions with the phosphate. Bub1 does not have an
HRD motif. It has an HGD motif instead (Figure S2). Indeed,
the pS969 residue in Bub1 does not make favorable interactions
with the catalytic loop or other structural elements (Figure 2E).
Instead, the unfavorable interactions between pS969 and the
negatively charged D917 and E967 residues provide a driving
force for the phosphorylation-induced conformation change. In
the unphosphorylated conformation, S969 is located in close
proximity to D917 and E967 (Figure 3C). If there were no confor-
mational changes, the phosphate group on pS969 would have
developed unfavorable electrostatic interactions with these
two negatively charged residues. In phosphorylated Bub1,
pS969 points away from D917 and E967, alleviating these
clashes (Figure 3D).
Finally, most kinases have a characteristic APE motif at the
end of the activation segment. The glutamate in this motif forms
a salt bridge with a highly conserved arginine in the C-terminal
region of the kinase (Figure S2). In Bub1, this APE motif is re-
placed by a CVE motif. The carboxyl group of the glutamate
(E975) does not interact with an arginine, but forms a hydrogen
bond with its own backbone amide. In the unphosphorylated
conformation, the cysteine in this motif (C973) and M976 partic-
ipate in hydrophobic interactionswithW982 and I986 (Figure 3C).
E967 points toward this hydrophobic core. In the phosphory-
lated conformation, C966 is included in this core, whereas
E967 points away (Figure 3D). The inclusion of the hydrophobic
C966 (as opposed to the charged E967) in the hydrophobic
core provides another driving force for the phosphorylation-
dependent conformational change.
Bub1 S969 Phosphorylation Is Required for H2A
Phosphorylation in Human Cells
To test whether Bub1 S969 phosphorylation was required for
Bub1-dependent H2A phosphorylation in human cells, weAll rights reserved
Figure 3. S969 Phosphorylation Reorga-
nizes the P+1 Loop through Introducing
Electrostatic Repulsion
(A and B) Zoomed in views of ribbon diagrams of
unphosphorylated Bub1724–1085 and phosphory-
lated Bub1740–1085 with residues in the N-terminal
half of the activation segment and their interacting
residues shown in sticks. Color schemes are the
same as in Figure 2. F736 and V738 (red labels) in
Bub1724–1085 are replaced by a proline introduced
by the cloning sites in Bub1740–1085.
(C and D) Zoomed in views of ribbon diagrams of
unphosphorylated Bub1724–1085 and phosphory-
lated Bub1740–1085, with residues in the C-terminal
half of the activation segment and their interacting
residues shown in sticks.
See also Figure S2.
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Crystal Structure of Activated Bub1created HeLa cell lines that stably expressed RNAi-resistant
GFP-Bub1 WT or mutants at comparable levels. In HeLa cells
depleted of endogenous Bub1 with RNAi, expression of GFP-
Bub1 WT, but not the kinase-dead mutant D946N, restored
H2A-pT120 levels in mitotic cell lysates (Figure 4A) and on
mitotic kinetochores (Figures 4B and 4C). Expression of
GFP-Bub1 S969A did not efficiently restore H2A-pT120 in
Bub1 RNAi cells, whereas expression of GFP-Bub1 S969D
did. Consistent with the role of H2A-pT120 in enriching
Sgo1 at centromeres (Kawashima et al., 2010; Liu et al.,
2013a), cells expressing Bub1 S969A had reduced Sgo1
staining at centromeres (Figure S3). These results strongly
suggest that S969 phosphorylation of Bub1 is critical for
H2A-T120 phosphorylation by Bub1 in human cells. GFP-
Bub1 DTPR fully supported H2A-T120 phosphorylation and
centromeric localization of Sgo1 (Figures 4 and S3), again
indicating that the TPR domain of Bub1 is dispensable for
its kinase activity.
Bub1 S969 Phosphorylation Is Constitutive during the
Cell Cycle
H2A-pT120 is enriched at kinetochores only during mitosis, but
not in interphase (Kawashima et al., 2010). We tested whether
Bub1-pS969 levels were elevated during mitosis. Unexpectedly,
we found that pS969 signals of endogenous Bub1 immunopre-Structure 22, 1616–1627, November 4, 2014 ªcipitated from mitotic (nocodazole-ar-
rested) or G1/S (thymidine-arrested) cells
did not change appreciably (Figure 5A).
Likewise, inactivation of the spindle
checkpoint with the Aurora kinase inhibi-
tor ZM447439 in cells treated with Taxol
and the proteasome inhibitor MG132
did not reduce pS969 signals of ectopi-
cally expressed GFP-Bub1 (Figure 5B).
Consistently, pS969 signals of GFP-
Bub1 did not change during mitotic exit
following nocodazole-arrest release (Fig-
ure 5C). These results indicate that Bub1
S969 phosphorylation is not regulated
during the cell cycle. This finding is
consistent with the fact that Myc-Bub1proteins isolated from cells in different cell cycle stages have
similar kinase activities (Figure 1).
We then tested whether any of known Bub1-interacting pro-
teins regulated S969 phosphorylation (Figure 5D). HeLa cells
were depleted of Knl1, BubR1, or Bub3 with siRNAs. We code-
pleted Cdc20 from these checkpoint-deficient cells to block
them in mitosis. Bub1-pS969 signals remained unchanged in
all samples. Thus, binding of Knl1, Bub3, or BubR1 to Bub1 is
not required for Bub1 S969 phosphorylation.
Kinetochore Targeting of Bub1 Is Required for Enriching
H2A-pT120 at Mitotic Kinetochores
Because Bub1 S969 phosphorylation is not elevated during
mitosis, increased Bub1 activation during mitosis does not un-
derlie the mitosis-specific enrichment of H2A-pT120 at kineto-
chores. Bub1 only localizes to kinetochores during mitosis,
and this localization relies on the kinetochore scaffolding protein
Knl1 (Kiyomitsu et al., 2007; Krenn et al., 2014; Primorac et al.,
2013; Vleugel et al., 2013; Yamagishi et al., 2012; Zhang et al.,
2014). We next examined whether the Knl1-dependent kineto-
chore targeting of Bub1 was required for the kinetochore enrich-
ment of H2A-pT120. As expected, depletion of Bub1 abolished
H2A-pT120 signals in mitotic cells, including those at kineto-
chores (Figures 5E and 5F). Depletion of Knl1 abolished the
kinetochore H2A-pT120 signals (Figures 5E and 5F), without2014 Elsevier Ltd All rights reserved 1621
Figure 4. Bub1 S969 Phosphorylation Is
Required for H2A-pT120 in Human Cells
(A) HeLa cells stably expressing the indicated
GFP-Bub1 proteins were transfected with siBub1
and arrested in mitosis. Cell lysates were blotted
with the indicated antibodies.
(B) Cells in (A) were stained with DAPI (blue in
overlay), CREST (red), GFP, or H2A-pT120 (green).
Selected regions were magnified in insets.
(C) Quantification of the normalized kinetochore
H2A-pT120 signals of cells in (B).
See also Figure S3.
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Crystal Structure of Activated Bub1reducing the total H2A-pT120 signals in cell lysates (Figure 5G).
Consistently, H2A-pT120 staining at other chromosome regions
was increased in Knl1 RNAi cells (Figure 5E). Thus, the kineto-
chore targeting of Bub1 is responsible for enriching H2A-
pT120 at kinetochores during mitosis.
Bub1 S969 Phosphorylation Occurs through
Intramolecular Autophosphorylation
Recombinant human Bub1 WT, but not the kinase-dead mutant
D946N, purified from insect cells was phosphorylated at S969,
indicating that Bub1 could undergo autophosphorylation at this
site (Figure 1E). Consistently, Bub1 D946N expressed in human
cells had no detectable S969 phosphorylation with or without the
depletion of the endogenous Bub1 (Figure 6A). In contrast, when
expressed in human cells, another kinase-dead mutant D917N
still had detectable, albeit reduced, S969 phosphorylation (Fig-
ures 1F and 6A). S969 phosphorylation of Bub1 D917N was un-
likely mediated by the endogenous Bub1 in human cells, as
depletion of Bub1 did not reduce this phosphorylation (Fig-
ure 6A). Moreover, recombinant purified Bub1 D917N retained
about 30% S969 phosphorylation, whereas D946N had no
detectable pS969 signals (Figure 6B).
The different behaviors of the two kinase-dead Bub1 mutants,
D946N and D917N, in supporting S969 phosphorylation were
unexpected. D946 coordinates Mg2+ ions and is required for
ATP binding (Figure 6C). D917 acts as the catalytic base to de-
protonate the hydroxyl group in substrates, thus promoting g
phosphate transfer. The D946N mutant cannot bind ATP,
whereas D917N is expected to retain ATP binding but cannot
transfer the g phosphate to substrates. The fact that Bub1
D946N does not have pS969 signals clearly indicates that
S969 phosphorylation occurs through either intermolecular or in-
tramolecular autophosphorylation, as opposed to through
another kinase. Because D917N retains ATP binding, it may still
support S969 phosphorylation to some degree, provided that the
g phosphate transfer to S969 does not strictly require D917.1622 Structure 22, 1616–1627, November 4, 2014 ª2014 Elsevier Ltd All rights reservedActivation of many kinases involves the
autophosphorylation of their activation
loop (Nolen et al., 2004). These autophos-
phorylation events have generally been
thought to occur through an intermolec-
ular (or trans) mechanism, in which two
molecules of the same kinase phosphor-
ylates each other (Figure 6D). Recent
studies have shown that certain kinasescan undergo intramolecular autophosphorylation (Dodson
et al., 2013; Hu et al., 2013). The structural basis of such a trans-
fer has not been established, however. As discussed above, our
unphosphorylated Bub1 structure contains ADP and a second
Mg2+ ion with three bound water molecules at the site normally
occupied by the g phosphate. The Mg2+ and water molecules
might serve as a mimic of the g phosphate, similar to AlF4
.
S969 in the unphosphorylated Bub1 lies in close proximity to
and points toward D917 and the second Mg2+ ion bound at the
active site. It is poised to accept the phosphate group from
ATP. This conformation of Bub1 is thus compatible for an intra-
molecular phosphate transfer from ATP to S969.
In the current conformation, the distance between the Mg2+
ion (as a putative g phosphate mimic) and the hydroxyl group
of S969 is too far for phosphate transfer. On the other hand,
the B factors of the P+1 loop are substantially higher than those
of the rest of the protein. The presumed high mobility of this loop
might allow S969 to transiently engage the catalytic site and
enable phosphate transfer. We note that even though Bub1
was crystalized in the presence of ATP the structures of both
phosphorylated and unphosphorylated Bub1 contained ADP at
their active site, presumably because Bub1 had measurable
ATPase activity in the absence of substrates (Figure S4A). This
ATPase activity might compete with and limit the extent of
Bub1 autophosphorylation.
Next, we expressed and purified two different human Bub1
fragments containing the kinase domain, Bub1740–1085 and
Bub1527–1085, from insect cells. Both fragments underwent
S969 phosphorylation (Figure 6E). Phosphatase treatment
greatly reduced pS969 signals of Bub1740–1085. Incubation of de-
phosphorylated Bub1740–1085 with ATP restored the pS969
signal. As shown above, Bub1740–1085 D946N could not undergo
S969 phosphorylation. Importantly, active Bub1527–1085 could
not phosphorylate the kinase-dead Bub1740–1085 D946N at
S969, indicating that intermolecular Bub1 autophosphorylation
was inefficient. This finding was consistent with the fact that
Figure 5. H2A-pT120 Accumulation at Mitotic Kinetochores Relies on Kinetochore Targeting of Constitutively Active Bub1
(A) Endogenous Bub1 was IPed from nocodazole (Noc) or thymidine (Thy) arrested HeLa cells and blotted with anti-Bub1 or Bub1-pS969 antibodies.
(B) HeLa cells stably expressingGFP-Bub1were treatedwith Taxol andMG132 in the absence () or presence (+) of ZM447439 (ZM). The anti-GFP IPwas blotted
with GFP or Bub1-pS969 antibodies.
(C) HeLa cells stably expressing GFP-Bub1 were treated with thymidine (Thy) or released from nocodazole arrest for the indicated durations. The mitotic index of
each sample was shown at the bottom. The anti-GFP IP was blotted with GFP or Bub1-pS969 antibodies.
(D) HeLa cells were transfected with the indicated siRNAs and blocked in mitosis with Cdc20 depletion. The lysates and anti-Bub1 IP were blotted with the
indicated antibodies.
(E) Mitotic HeLa cells mock depleted or depleted of Bub1 or Knl1 were stained with DAPI (blue in overlay), CREST (red), and H2A-pT120 (green). Selected regions
were magnified and shown in insets.
(F) Quantification of the normalized kinetochore H2A-pT120 signals of cells in (E).
(G) Lysates of cells in (E) were blotted with the indicated antibodies.
Structure
Crystal Structure of Activated Bub1ectopically expressed Bub1 D946N was not phosphorylated by
the endogenous Bub1 in human cells (Figure 6A). Moreover,
the extent of Bub1 S969 phosphorylation in vitro was relatively
insensitive to the concentration of Bub1 (Figure S4B), a phenom-
enon expected of intramolecular reactions. In contrast, T180
phosphorylation at the activation loop of the kinase Mst2 (which
was known to undergo intermolecular autophosphorylation) was
greatly reduced at lower kinase concentrations (Ni et al., 2013).
On the other hand, we cannot exclude the possibility that l phos-
phatase was not completely inactivated, and Mst2-pT180 was a
much better substrate for the phosphatase. Collectively, these
results suggest that Bub1 might undergo intramolecular auto-
phosphorylation at S969.
Finally, we tested whether the residual S969 phosphorylation
in Bub1 D917N mutant was mediated by E967, which wasStructure 22, 1616–16located near S969 (Figure 6C). Although the E967Q mutation
slightly reduced S969 phosphorylation, it did not reduce the re-
sidual S969 phosphorylation in the D917N mutant (Figure 6B).
Thus, E967 is not responsible for S969 phosphorylation in the
kinase-dead D917N mutant. Interestingly, the D917N/E967Q
double mutant completely lacked ATPase activity (Figure S4A),
indicating that the autophosphorylation and ATPase activities
of Bub1 can be uncoupled.
DISCUSSION
We have discovered an autophosphorylation event in the activa-
tion segment of human Bub1 required for its activation toward
histone H2A. This S969 phosphorylation has several unusual fea-
tures. First, it occurs on the substrate-binding loop, not on the27, November 4, 2014 ª2014 Elsevier Ltd All rights reserved 1623
Figure 6. Bub1 S969 Phosphorylation Occurs through Intramolecular Autophosphorylation
(A) HeLa cells stably expressing the indicated GFP-Bub1 proteins were transfected with (+) or without () siBub1 and arrested in mitosis. The total lysates and
GFP IP were blotted with the indicated antibodies. The relative intensities of pS969 signals were shown below each sample.
(B) The indicated recombinant purified Bub1740–1085 proteins were blotted with anti-Bub1 and Bub1-pS969 antibodies. The relative intensities of pS969 signals
were shown below each sample.
(C) Ribbon diagram of the active site of unphosphorylated Bub1, with ADP and key residues in sticks. Mg2+ ions and water molecules are shown as gray and red
spheres, respectively. Color scheme is the same as in Figure 2.
(D) Schematic drawing of intermolecular and intramolecular autophosphorylation.
(E) The indicated purified recombinant Bub1 proteins were incubated in the presence (+) or absence () of l phosphatase or ATP. The reaction mixtures were
blotted with anti-Bub1 or Bub1-pS969 antibodies.
See also Figure S4.
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Crystal Structure of Activated Bub1activation loop. Second, activation-loop phosphorylation typi-
cally activates the kinase through establishing favorable interac-
tions between the phosphoresidue and a basic residue in the
catalytic loop and inducing a disordered-to-ordered conforma-
tional transition of the activation loop (Nolen et al., 2004). In
contrast, S969 phosphorylation of Bub1 reorganizes the P+1
loop through introducing unfavorable interactions between the
phosphoresidue and neighboring acid residues, including the
catalytic aspartate. Third, S969 phosphorylation of Bub1 only
stimulates its activity toward H2A but has no effect on its activity
toward Cdc20. This substrate-specific activation is unusual.
Finally, our structural and biochemical analyses suggest that
the activating phosphorylation of Bub1 occurs through an intra-
molecular reaction and that this reaction does not strictly require
the catalytic aspartate. Although intramolecular autophosphory-1624 Structure 22, 1616–1627, November 4, 2014 ª2014 Elsevier Ltdlation has been reported for certain kinases (Dodson et al., 2013;
Hu et al., 2013), our structure of unphosphorylated Bub1 pro-
vides the first glimpse of how this intramolecular reaction might
proceed.
It is surprising that Bub1 S969 phosphorylation does not
strictly require the catalytic aspartate, D917. This suggests that
Bub1 uses a noncanonical mechanism for catalysis, at least in
the context of autophosphorylation. We initially suspected a
neighboring glutamate performing the catalytic functions in the
absence of D917, but this was not the case. Because the
D946N mutation completely abolishes S969 phosphorylation, it
is possible that D946 performs the catalytic function in addition
to its known roles in coordinating Mg2+ and facilitating ATP bind-
ing. Alternatively, the many unique features of Bub1 enable it to
undergo cis autophosphorylation to some degree without aAll rights reserved
Figure 7. Bub1 Is a Constitutively Active
Kinase with an Organized R Spine
(A) Comparison of the R spines of PKA and Bub1.
Cartoon diagrams of PKA (left) and Bub1 (right),
with the R spine residues shown in sticks. The van
der Waals surface of the same residues is also
shown.
(B) Schematic drawing of dimerization-stimulated
intramolecular autophosphorylation (as proposed
for RAF) and unassisted intramolecular auto-
phosphorylation (as proposed for Bub1).
(C) UV traces of gel filtration chromatography of
molecular weight standard and Bub1740–1085.
See also Figure S2.
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Crystal Structure of Activated Bub1catalytic residue. It will be interesting to test whether intramolec-
ular autophosphorylation events in other kinases can also occur
in the absence of a catalytic base.
Active kinases contain an internal, spatial motif termed the
regulatory (R) spine, which is formed by nonconsecutive hydro-
phobic residues (Taylor and Kornev, 2011). Both unphosphory-
lated and pS969 Bub1 have a well-formed R spine (Figures 7A
and S2), even though the residues that make up the R spine in
Bub1 are different from those in other kinases, such as PKA.
Thus, Bub1 is a constitutively active kinase. S969 phosphoryla-
tion only enhances its activity toward H2A, but is not required
for all of its activities, including autophosphorylation and phos-
phorylation of Cdc20.
The kinase RAF undergoes dimerization-dependent auto-
phosphorylation (Hu et al., 2013). In the dimer, one kinase
molecule (termed the activator) allosterically activates the other
(termed the receiver), which undergoes intramolecular auto-
phosphorylation (Figure 7B). We do not have evidence that
dimerization of the Bub1 kinase domain is involved in its auto-
phosphorylation. Unlike RAF, the kinase domain of Bub1 is
monomeric in solution. The apparent molecular weight based
on gel filtration chromatography is 43 kDa (Figure 7C), whereas
the calculated molecular weight of the Bub1 kinase domain is
41 kDa. A crystal contact involving the C-terminal helix of
Bub1 exists in both the unphosphorylated and phosphorylated
structures, but it is not immediately apparent how this contact
could be required for Bub1 activation. More importantly, our
previous work on the unphosphorylated Bub1 has established
the importance of the N-terminal extension in the activity of
Bub1 (Kang et al., 2008). This extension restricts the movement
of the aC helix and promotes the formation of the R spine and
hence the active conformation of the kinase. Thus, our results
favor the possibility that Bub1 undergoes unassisted, intramo-Structure 22, 1616–1627, November 4, 2014 ªlecular autophosphorylation (Figure 7B),
without the need for allosteric activation
from another Bub1 molecule, at least in
the context of the isolated Bub1 kinase
domain.
Bub1 installs the H2A-pT120 mark at
mitotic kinetochores, which recruits
Sgo1-PP2A to centromeres to protect
centromeric cohesion. The H2A-pT120
mark is not enriched at kinetochores in
interphase cells. On the other hand,Bub1 S969 phosphorylation is not regulated during the cell cycle
and is not influenced by known Bub1-binding proteins. Consis-
tent with the constitutive nature of S969 phosphorylation, the
budding yeast Bub1 has an aspartate, instead of a serine, at
that position (Figure 1B). The mitosis-specific enrichment of
H2A-pT120 at kinetochores is thus not caused by enhanced
Bub1 autophosphorylation and activation, but is instead
controlled by mitosis-specific targeting of already activated
Bub1 to kinetochores. Indeed, recent studies have established
an elaborate mechanism for targeting Bub1 to kinetochores spe-
cifically duringmitosis, which involves the binding of Bub1–Bub3
to Mps1-dependent phosphomotifs in Knl1 (Kiyomitsu et al.,
2007; Krenn et al., 2014; Primorac et al., 2013; Vleugel et al.,
2013; Yamagishi et al., 2012; Zhang et al., 2014).
In conclusion, this study provides structural and functional in-
sights into the regulation of the key mitotic kinase Bub1 and
highlights a mode of substrate-specific kinase activation
through intramolecular autophosphorylation of the substrate-
binding loop.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The Bub1 kinase domain (residues 740–1085) was expressed and purified
essentially as described (Kang et al., 2008). Briefly, Sf9 cells infected
with the human Bub1 baculovirus were harvested at 48 hr after infection
and lysed by sonication. His6-Bub1
740–1085 was purified with the Ni2+-NTA
resin (QIAGEN) and incubated with tobacco etch virus protease and
1 mM ATP overnight at 4C. Phosphorylated Bub1740–1085 was further pu-
rified with resource S and Superdex 200 columns (GE Healthcare).
Bub1740–1085 mutants were expressed and purified similarly. The purified
Bub1740–1085 was further incubated with 10 mM ATP in the storage buffer
(20 mM Tris-HCl [pH 7.7], 150 mM NaCl, 10 mM MgCl2, 10 mM DTT) for
30 min at room temperature and was concentrated to 6 mg/ml for
crystallization.2014 Elsevier Ltd All rights reserved 1625
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The Bub1740–1085 crystals were grown at 20C with the hanging drop method
by mixing equal volumes of the protein solution with the precipitant solution
(20% PEG3350, 1% tryptone, 10 mM dithiothreitol (DTT), 0.1 M 2-[4-(2-hy-
droxyethyl)piperazin-1-yl]ethanesulfonic acid [HEPES] [pH 7.0]). Crystals
grew to full size in 2 days. For X-ray data collection, crystals were transferred
to a cryoprotectant solution containing 15% MPD, 22% PEG3350, and 0.1 M
HEPES (pH 7.0) and were flash frozen in a liquid nitrogen stream. The crystal
diffracted to aminimumBragg’s spacing of 2.20 A˚ and exhibited the symmetry
of space group of P21 with cell dimensions of a = 90 A˚, b = 47 A˚, c = 93 A˚, b =
107. Diffraction data were collected at 19-ID (SBC-CAT) at the Advanced
Photon Source (Argonne National Laboratory) and processed with HKL3000
(Minor et al., 2006).
Phase for Bub1740–1085 was obtained bymolecular replacement with Phaser
using the coordinates of unphosphorylated Bub1 (PDB code: 3E7E) as the
initial search model (McCoy, 2007). Iterative model building and refinement
were performed with COOT and Phenix (Adams et al., 2010; Emsley and Cow-
tan, 2004). The final model of Bub1740–1085 (Rwork = 22.9%, Rfree = 26.8%) con-
tained two molecules per asymmetric unit. Each molecule has 331 residues,
one ADP, two Mg2+ ions, one Cl ion, and 237 water molecules. The structure
has good geometry with 95.8% residues in most favored regions of the
Ramachandran plot, 4.2% in the allowed region, and none in the disallowed
region, as defined by MolProbity (Chen et al., 2010).
Cell Culture and Transfection
HeLa Tet-On cells (Invitrogen) weremaintained in Dulbecco’smodified Eagle’s
medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen),
10 mM L glutamine (Invitrogen), and 100 mg/ml penicillin and streptomycin
(Invitrogen). To arrest cells at G1/S, cells were treated with 2.5 mM thymidine
for 18 hr. To arrest cells in mitosis, cells released from thymidine for 7 hr were
treated with 2.5 mM nocodazole or 200 nM Taxol for another 7–8 hr. To inacti-
vate the spindle checkpoint while keeping cells in mitosis, the Aurora kinase
inhibitor ZM447439 (4 mM; Selleck Chemicals) andMG132 (10 mM; Boston Bio-
chem) were added to Taxol-treated cells for 1.5 hr.
Plasmid transfection was performed with the Effectene reagent (QIAGEN)
following the manufacturer’s protocols. GFP-Bub1 WT or mutant stable cell
lines were made by transfecting HeLa Tet-On cells with pTRE2-GFP-Bub1
WT or mutant plasmids and selecting resistant colonies with 300 mg/ml hy-
gromycin (Clontech). Single clones were picked and screened for inducible
expression of GFP-Bub1 proteins in the presence of 1 mg/ml doxycycline
(Clontech).
For RNAi experiments, HeLa Tet-On cells were transfected with 5 nM siRNA
using Lipofectamine RNAiMax (Invitrogen) and were harvested at 48–60 hr af-
ter transfection. The siRNA oligonucleotides for Bub1, Knl1, BubR1, and Bub3
were purchased from Thermo Scientific. The sequences of these siRNAs are
siBub1c, CCCAUUUGCCAGCUCAAGCdTdT; siKnl1, GGAAAUAGAUAACGA
AAGU; siBubR1, CAAGAUGGCUGUAUUGUUU; and siBub3, CAAGCAGGG
UUAUGUAUUA. The Cdc20 siRNA was purchased from Ambion (Silencer
Select Pre-designed siRNA, ID s2748).
Antibodies, Immunoblotting, and IP
Antibodies against Bub1, Cdc20, BubR1, and H2A-pT120were described pre-
viously (Liu et al., 2013a; Tang et al., 2001). The a-Cdc20-pS153 antibody was
made in an in-house facility by immunizing rabbits with a Cdc20-pS153 con-
taining peptide coupled to hemocyanin (Sigma). The a-Bub1-pT968/pS969
antibody was produced in the same facility with a mixture of a pT968-contain-
ing peptide and a pS969-containing peptide. The a-Bub1-pS969 antibody was
subsequently purified with beads immobilized with the pS969 peptide. The
following antibodies were purchased from the indicated sources: mouse
a-Myc (9E10; Roche), mouse a-H2A (L8846; Cell Signaling), mouse a-tubulin
(DM1A; Sigma-Aldrich), mouse a GAPDH (6C5; Milipore), and CREST (Immu-
noVision). For quantitative immunoblotting, a rabbit immunoglobulin G (IgG)
(H+L) (Dylight 800 conjugates) and amouse IgG (H+L) (Dylight 680 conjugates)
(Cell Signaling) were used as secondary antibodies. The blots were scanned
and quantified with the Odyssey Infrared Imaging System (LI-COR).
For IP, antibodies against Myc, Bub1, or GFPwere coupled to Affi-Prep Pro-
tein A beads (Bio-Rad) at a concentration of 1 mg/ml. Cells were lysed with the
lysis buffer (50 mM Tris-HCl [pH 7.7], 120 mM KCl, 0.1% NP-40, 5 mM NaF,1626 Structure 22, 1616–1627, November 4, 2014 ª2014 Elsevier Ltd0.3 mM Na3VO4, 10 mM b glycerophosphate, 0.5 mM okadaic acid, 1 mM
DTT) supplemented with protease inhibitor tablets (Sigma-Aldrich) and
Turbo-nuclease (Accelagen). After a 20 min incubation on ice, the lysate
was cleared by centrifugation. The supernatant was incubated with the anti-
body-coupled protein A beads for 2 hr at 4C. After washing, the beads
were boiled in SDS sample buffer and analyzed by SDS-PAGE followed by
immunoblotting.
Kinase Assays
WT or mutant Bub1 proteins purified from Sf9 cells or immunoprecipitated
from human cells were incubated with the kinase buffer (50 mM Tris-HCl [pH
7.7], 100 mM NaCl, 10 mMMgCl2, 5 mM NaF, 0.1 mM Na3VO4, 20 mM b glyc-
erophosphate, 1 mM DTT) for 15 or 30 min at room temperature or 30C with
1 mg recombinant Cdc20 protein or 6 mg bulk histones from calf thymus
(Sigma-Aldrich) in 20 ml Kinase Buffer supplemented with 100 mMATP. The re-
action mixtures were quenched with SDS sample buffer and analyzed by SDS-
PAGE followed by Cdc20-pS153 or H2A-pT120 blotting.
For autophosphorylation experiments, Bub1 proteins purified from Sf9 cells
were treated with l phosphatase (New England Biolabs) for 1 hr at 30C. The
phosphatase reactions were stopped by a buffer containing 5 mM Na3VO4,
10 mM NaF, and 20 mM b glycerophosphate. The reaction mixture was then
incubatedwith 0.1mMATP in kinase buffer for another 1 hr at 30Cand blotted
with anti-Bub1-pS969.
Immunofluorescence
Mitotic cells were washed once with PBS and incubated with 75 mM KCl for
15 min at 37C. After the hypotonic treatment, the cells were spun onto micro-
scopeslideswith aShandonCytospin centrifuge.Cellswere first extractedwith
PBS containing 0.2% Triton X-100 for 2 min and then fixed in 4% paraformal-
dehyde for 5 min. After washing three times with PBS containing 0.2% Triton
X-100, the cells were incubated with primary antibodies in PBS containing
0.2% Triton X-100 and 3% BSA at 4C for 10 hr. The cells were washed three
times with PBS containing 0.2% Triton X-100 and incubated with fluorescent
secondary antibodies (Molecular Probes) in PBS containing 0.2% Triton
X-100 and 3% BSA for 1 hr at room temperature. The cells were again washed
three times with PBS containing 0.2% Triton X-100 and stained with 1 mg/ml
DAPI for 3 min. After the final washes with PBS, the slides were sealed and
viewed using a 1003 objective on a Deltavision microscope (Applied Preci-
sion). A series of z stack imageswas captured at 0.2mm intervals, deconvolved,
and projected. Image processing and quantification were done with ImageJ.
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